Early role for IL-6 signalling during generation of induced pluripotent stem cells revealed by heterokaryon RNA-Seq

Nature Cell Biology

Volumn 15, Issue 10, 2013, Pages 1244-1252

  Brady, Jennifer J ^a   Li, Mavis ^b,c   Suthram, Silpa ^a   Jiang, Hui ^b,c,d   Wong, Wing H ^c   Blau, Helen M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Stanford University   (United States)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; KRUPPEL LIKE FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN KINASE PIM 1; TRANSCRIPTION FACTOR SOX2;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYONIC STEM CELL; GENE EXPRESSION; GENETIC TRANSDUCTION; HETEROKARYON; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; ONCOGENE C MYC; PIM1 GENE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RNA SEQUENCE; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS;

ANIMALS; CYTOKINE RECEPTOR GP130; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INTERLEUKIN-6; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; NUCLEAR REPROGRAMMING; SEQUENCE ANALYSIS, RNA; SIGNAL TRANSDUCTION;

IPS;

EID: 84885183807     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb2835     Document Type: Article

References (37)

1. Vierbuchen, T. & Wernig, M. Molecular roadblocks for cellular reprogramming. Mol. Cell 47, 827-838 (2012).
2. Yamanaka, S. & Blau, H. M. Nuclear reprogramming to a pluripotent state by three approaches. Nature 465, 704-712 (2010).
3. Bhutani, N. et al. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 463, 1042-1047 (2010).
4. Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L. & Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5, 621-628 (2008).
5. Tarazona, S., Garcia-Alcalde, F., Dopazo, J., Ferrer, A. & Conesa, A. Differential expression in RNA-seq: a matter of depth. Genome Res. 21, 2213-2223 (2011).
6. Thomas, P. D. et al. PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res. 31, 334-341 (2003).
7. Hirano, T., Ishihara, K. & Hibi, M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19, 2548-2556 (2000).
8. Heinrich, P. C. et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374, 1-20 (2003).
9. Puthier, D., Bataille, R. & Amiot, M. IL-6 up-regulates mcl-1 in human myeloma cells through JAK/STAT rather than ras/MAP kinase pathway. Eur. J. Immunol. 29, 3945-3950 (1999).
10. Assou, S. et al. A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells 25, 961-973 (2007).
11. Bhattacharya, B. et al. Gene expression in human embryonic stem cell lines: unique molecular signature. Blood 103, 2956-2964 (2004).
12. Yang, J., Gao, C., Chai, L. & Ma, Y. A novel SALL4/OCT4 transcriptional feedback network for pluripotency of embryonic stem cells. PLoS One 5, e10766 (2010).
13. Sridharan, R. et al. Role of the murine reprogramming factors in the induction of pluripotency. Cell 136, 364-377 (2009).
14. Buganim, Y. et al. Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell 150, 1209-1222 (2012).
15. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
16. Cheney, I. W. et al. Identification and structure-activity relationships of substituted pyridones as inhibitors of Pim-1 kinase. Bioorganic Med. Chem. Lett. 17, 1679-1683 (2007).
17. Pierce, A. C., Jacobs, M. & Stuver-Moody, C. Docking study yields four novel in- hibitors of the protooncogene Pim-1 kinase. J. Med. Chem. 51, 1972-1975 (2008).
18. Lee, J. et al. Activation of innate immunity is required for efficient nuclear reprogramming. Cell 151, 547-558 (2012).
19. Nihira, K. et al. Pim-1 controls NF-kappaB signalling by stabilizing RelA/p65. Cell Death Differ. 17, 689-698 (2010).
20. Pasque, V., Jullien, J., Miyamoto, K., Halley-Stott, R. P. & Gurdon, J. B. Epigenetic factors influencing resistance to nuclear reprogramming. Trends Genet. 27, 516-525 (2011).
21. Byrne, J. A. et al. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature 450, 497-502 (2007).
22. Hanna, J. et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462, 595-601 (2009).
23. Bhutani, N. et al. A critical role for AID in the initiation of reprogramming to induced pluripotent stem cells. FASEB J. 27, 1107-1113 (2013).
24. Lin, C. Y. et al. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151, 56-67 (2012).
25. Gilbert, L. A. & Hemann, M. T. Context-Specific roles for paracrine IL-6 in lymphomagenesis. Genes Dev. 26, 1758-1768 (2012).
26. Soufi, A., Donahue, G. & Zaret, K. S. Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell 151, 994-1004 (2012).
27. Aho, T. L. et al. Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site. FEBS Lett. 571, 43-49 (2004).
28. Van Mourik, M. S., Macklon, N. S. & Heijnen, C. J. Embryonic implantation: cytokines, adhesion molecules, and immune cells in establishing an implantation environment. J. Leukocyte Biol. 85, 4-19 (2009).
29. Tsubouchi, T. et al. DNA synthesis is required for reprogramming mediated by stem cell fusion. Cell 152, 873-883 (2013).
30. Foshay, K. M. et al. Embryonic stem cells induce pluripotency in somatic cell fusion through biphasic reprogramming. Mol. Cell 46, 159-170, (2012).
31. Holmberg, J. & Perlmann, T. Maintaining differentiated cellular identity. Nat. Rev. Genet. 13, 429-439 (2012).
32. Silva, J., Chambers, I., Pollard, S. & Smith, A. Nanog promotes transfer of pluripotency after cell fusion. Nature 441, 997-1001 (2006).
33. Pasque, V., Halley-Stott, R. P., Gillich, A., Garrett, N. & Gurdon, J. B. Epigenetic stability of repressed states involving the histone variant macroH2A revealed by nuclear transfer to Xenopus oocytes. Nucleus 2, 533-539 (2011).
34. Huang, X. A. & Lin, H. The miRNA regulation of stem cells. WIREs Membr. Transp. Signal. 1, 83-95 (2012).
35. Graf, T. Historical origins of transdifferentiation and reprogramming. Cell Stem Cell 9, 504-516 (2011).
36. Salero, E. et al. Adult human RPE can be activated into a multipotent stem cell that produces mesenchymal derivatives. Cell Stem Cell 10, 88-95 (2012).
37. Marson, A. et al. Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 3, 132-135 (2008).